AJR ARRS PQI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Takayasu, K.
Right arrow Articles by Ohto, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Takayasu, K.
Right arrow Articles by Ohto, M.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Hotlight (NEW!)
Right arrow
What's Hotlight?
AJR 2000; 175:699-704
© American Roentgen Ray Society


Comparison of CT Findings with Resected Specimens After Chemoembolization with Iodized Oil for Hepatocellular Carcinoma

Kenichi Takayasu1, Shigeki Arii2, Naoki Matsuo3, Masaharu Yoshikawa4, Munemasa Ryu5, Ken Takasaki6, Morio Sato7, Naoki Yamanaka8, Yoshiyuki Shimamura9 and Masao Ohto4

1 Department of Diagnostic Radiology, National Cancer Center Hospital, 5-1-1, Tsukiji, Chuo-ku, Tokyo 114-0045, Japan.
2 First Department of Surgery, Kyoto University, 54, Kawara-cho, Seigoin, Sakyo-ku, Kyoto 606-8507, Japan.
3 Department of Radiology, Nara Prefectural Medical College, 840, Shijo-cho, Kashihara, Nara 634-8522, Japan.
4 First Department of Medicine, Chiba School of Medicine, 1-8-1, Inohana, Chuo-ku, Chiba 260-8766, Japan.
5 Department of Surgery, National Cancer Center Hospital East, 6-5-1, Kashiwanoha, Kashiwa, Chiba 277-0882, Japan.
6 Department of Surgery, Tokyo Women's Medical College, 8-1, Kawada-cho, Shinjuku-ku, Tokyo 162-8666, Japan.
7 Department of Radiology, Wakayama Prefectural Medical College, 811-1, Kimidera, Wakayama 641-8509, Japan.
8 First Department of Surgery, Hyogo School of Medicine, 1-1, Bukogawa-cho, Nishimiya, Hyogo 663-8501, Japan.
9 Department of Surgery, Chiba-nishi Hospital, 107-1, Kanegasaku, Matsudo, Chiba 270-2251, Japan.

OBJECTIVE. We assessed the role of dynamic CT in the evaluation of the efficacy of transarterial chemoembolization with iodized oil for hepatocellular carcinoma.

MATERIALS AND METHODS. We examined 41 hepatocellular carcinoma lesions (mean diameter, 5.0 cm) in 40 patients (mean age, 60.6 years) who underwent transarterial injection of iodized oil alone (n = 3) or emulsion of iodized oil and doxorubicin hydrochloride (n = 10) followed by gelatin sponge particles (n = 27) and subsequent hepatectomy. On dynamic CT performed within 3 weeks before oily transarterial chemoembolization and within 4 weeks before surgery, we calculated the rate of necrosis on the basis of the assumption that the portion that retained iodized oil represented necrosis. We also calculated the reduction rate of the tumor. CT findings were compared with pathologic findings of resected specimens.

RESULTS. Pathologic specimens and the necrosis rate measured on CT showed a good correlation (r = 0.83) when the portion of tumor that retained iodized oil was considered necrosis. No correlation existed if the portion that retained iodized oil was considered viable. We noted no significant correlation (r = 0.38) between the reduction rate of the tumor and necrosis rate. Also, we noted no correlation (r = 0.52) between the interval between transarterial oily chemoembolization and surgery and the reduction rate of the tumor.

CONCLUSION. CT is suitable for the evaluation of the efficacy of oily chemoembolization for hepatocellular carcinoma on the basis of the assumption that the portion of tumor that retains iodized oil is necrotic. The rate of tumor size reduction measured on CT did not correlate with the therapeutic effect of chemoembolization.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
RadiologyHome page
I. R. Kamel, E. Liapi, D. K. Reyes, M. Zahurak, D. A. Bluemke, and J.-F. H. Geschwind
Unresectable Hepatocellular Carcinoma: Serial Early Vascular and Cellular Changes after Transarterial Chemoembolization as Detected with MR Imaging
Radiology, February 1, 2009; 250(2): 466 - 473.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
E. Liapi, J.-F. Geschwind, J. A. Vossen, M. Buijs, C. S. Georgiades, D. A. Bluemke, and I. R. Kamel
Functional MRI Evaluation of Tumor Response in Patients with Neuroendocrine Hepatic Metastasis Treated with Transcatheter Arterial Chemoembolization
Am. J. Roentgenol., January 1, 2008; 190(1): 67 - 73.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
E. Liapi and J.-F. H. Geschwind
Transcatheter and Ablative Therapeutic Approaches for Solid Malignancies
J. Clin. Oncol., March 10, 2007; 25(8): 978 - 986.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
A. L. Keppke, R. Salem, D. Reddy, J. Huang, J. Jin, A. C. Larson, and F. H. Miller
Imaging of Hepatocellular Carcinoma After Treatment with Yttrium-90 Microspheres
Am. J. Roentgenol., March 1, 2007; 188(3): 768 - 775.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
H. S. Lim, Y. Y. Jeong, H. K. Kang, J. K. Kim, and J. G. Park
Imaging Features of Hepatocellular Carcinoma After Transcatheter Arterial Chemoembolization and Radiofrequency Ablation
Am. J. Roentgenol., October 1, 2006; 187(4): W341 - W349.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
H. S. Park, S. H. Lee, Y. I. Kim, J. S. Lee, M. K. Lim, J.-W. Park, J. H. Lee, and C.-M. Kim
Postbiopsy Arterioportal Fistula in Patients with Hepatocellular Carcinoma: Clinical Significance in Transarterial Chemoembolization
Am. J. Roentgenol., February 1, 2006; 186(2): 556 - 561.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
Y. Minami, M. Kudo, T. Kawasaki, M. Kitano, H. Chung, K. Maekawa, and H. Shiozaki
Transcatheter Arterial Chemoembolization of Hepatocellular Carcinoma: Usefulness of Coded Phase-Inversion Harmonic Sonography
Am. J. Roentgenol., March 1, 2003; 180(3): 703 - 708.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
K. Numata, K. Tanaka, T. Kiba, S. Matsumoto, S. Iwase, K. Hara, H. Kirikoshi, K. Morita, S. Saito, and H. Sekihara
Nonresectable Hepatocellular Carcinoma: Improved Percutaneous Ethanol Injection Therapy Guided by CO2-Enhanced Sonography
Am. J. Roentgenol., October 1, 2001; 177(4): 789 - 798.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2000 by the American Roentgen Ray Society.